ReviewResearch and practice in thrombosis and haemostasis2026
Pediatric venous thromboembolism: an illustrated review.
Review in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Venous thromboembolism (VTE) in children has historically been considered uncommon; however, it is increasingly recognized in hospitalized pediatric populations, and its incidence has risen over the past few decades. This can be attributed to several factors, including greater awareness of the condition, improved survival rates for children with chronic and complex medical conditions, increased use of supportive care (such as central venous catheters), and advancements in diagnostic imaging. Acquired conditions, such as infections, malignancies, cardiovascular diseases, and inflammatory bowel disease, are recognized as risk factors for VTE. Among these, the presence of a central venous catheter remains the most significant and common risk factor for pediatric VTE. In this review, we present and illustrate the pathophysiology and current treatment options for VTE in the pediatric population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.